NCT06762964View on ClinicalTrials.gov

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

PHASE2RecruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 16, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Fontan CirculationSingle Ventricle Heart DiseaseHFpEF - Heart Failure With Preserved Ejection Fraction
Interventions
DRUG

Dapagliflozin tablet

Patient will take a 10mg tablet of Dapagliflozin once daily for 24 weeks

DRUG

Placebo Tablet

Patient will take 10mg placebo tablet once daily for 24 weeks

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06762964 - CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation | Biotech Hunter | Biotech Hunter